miércoles, 25 de marzo de 2026
The Lancet Conference Alerts | Late-breaking content from the 2026 Critical Care Congress ++++
ARTICLES
Bedside identification of subphenotypes in acute respiratory failure (PHIND): a multicentre, observational cohort study
Open Access
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00040-8/fulltext?dgcid=hubspot_email_conferencealerts_sccm26&utm_campaign=conferencealerts&utm_medium=email&_hsenc=p2ANqtz-8qLhEiuKXsJMktNydnncwh9Dt1bst4dT1GuuKkDm5_ig_w_3kPVcSEySopIIQbxCimTD9vKGDrmWXFfIvFA5CR1zpAUQ&_hsmi=410263318&utm_content=410263318&utm_source=hs_email
Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trial
Open Access
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00047-0/fulltext?dgcid=hubspot_email_conferencealerts_sccm26&utm_campaign=conferencealerts&utm_medium=email&_hsenc=p2ANqtz--OypBatagx04y6KVmiS_my_7j87mT2Yr6P70cqTLe2XgTe035h7kWijePRM9WtxWdzGH0IYvRV7i9LfMOuZGvR0-bsVw&_hsmi=410263318&utm_content=410263318&utm_source=hs_email
Endotracheal surfactant for infants with life-threatening bronchiolitis (BESS): a randomised, blinded, sham-controlled, phase 2 trial
Open Access
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00008-1/fulltext?dgcid=hubspot_email_conferencealerts_sccm26&utm_campaign=conferencealerts&utm_medium=email&_hsenc=p2ANqtz--UFs1u2AQlMJ0WhG4Pr9KV_V0i_L3oW0s_WvvqW4NpmacxbHJ2wdr1yNMWBUeGiW7hEmVvoCKBGIL0u0ZbMNr6fzRPxQ&_hsmi=410263318&utm_content=410263318&utm_source=hs_email
Procalcitonin testing combined with NEWS2 evaluation compared with usual care based on NEWS2 for identification of sepsis and antibiotic initiation in the emergency department in England and Wales (PRONTO): a multicentre, randomised, controlled, open-label, phase 3 trial
Free to access with registration until Apr 1, 2026
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00433-3/fulltext?dgcid=hubspot_email_conferencealerts_sccm26&utm_campaign=conferencealerts&utm_medium=email&_hsenc=p2ANqtz--9A5ylQctJ0Y-CAlfvat3GI6M9doQ3LOIhIFydIeNPbEsVPnCEl5emsLWE4V1_jEfrujxMwJB7yVL3F87aq1895ucVTA&_hsmi=410263318&utm_content=410263318&utm_source=hs_email
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario